BUZZ-旺达敦促美国食品药品管理局放弃延长药品审查时限的建议;股价下跌

路透中文
Apr 09
BUZZ-旺达敦促<a href="https://laohu8.com/S/USFD">美国食品</a>药品管理局放弃延长药品审查时限的建议;股价下跌

4月9日 - ** 制药商旺达制药VNDA.O股价早盘下跌1.4%至7.19美元

** 该公司称已要求FDA撤回一项延长新药申请审查时间的提案

** 称该计划将废除一项要求在180天内完成药物审查的法律,转而允许将审查时间延长至10-12个月

** 补充说这一变化可能会推迟患者获得药品的时间,并增加小型制药商的不确定性

** 该提案将以不太严格的内部审查取代被拒药物的正式上诉程序 - VNDA

** 包括本交易日走势在内,该股今年累计下跌约 19%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10